
    
      Lorcaserin(Belviq) is a selective 5-hydroxytryptamine receptor agonist, witch is used long
      term for weight loss in those who are obese. Lorcaserin was approved in 2015 the Republic of
      Korea for weigh loss in those who are obese. A post-marketing surveillance was conducted
      following the approval to obtain data on the safety and efficacy of lorcaserin for weigh loss
      in real-world practice.
    
  